Literature DB >> 9288850

Molecular aspects of cellular responses to radiotherapy.

J Yarnold1.   

Abstract

Advances have been made in unravelling the molecular chains of cause and effect that determine cellular responses to radiotherapy, including cell cycle arrest, DNA repair and apoptosis. To begin with, cells must have mechanisms that enable them to sense DNA damage. Little was known about this until recently, when a DNA-protein kinase (DNA-PK) system for detecting radiation-induced strand breaks was described. The ataxia telangiectasia (ATM) gene has amino acid sequence similarities to DNA-PK, raising the possibility that the ATM protein also functions in some way as a sensor of DNA damage. However, just knowing the DNA damage is present is not enough. Signals must be transmitted via afferent biochemical pathways to proteins, such as p53, that determine which cellular responses are activated. The responses include cell cycle arrest, apoptosis and DNA repair, all of which relate closely to loss of clonogenic capacity and the outcome of treatment in our patients.

Entities:  

Mesh:

Year:  1997        PMID: 9288850     DOI: 10.1016/s0167-8140(97)00049-2

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  11 in total

1.  The involvement of p53 in dopamine-induced apoptosis of cerebellar granule neurons and leukemic cells overexpressing p53.

Authors:  D Daily; A Barzilai; D Offen; A Kamsler; E Melamed; I Ziv
Journal:  Cell Mol Neurobiol       Date:  1999-04       Impact factor: 5.046

2.  Inhibition of FASN expression enhances radiosensitivity in human non-small cell lung cancer.

Authors:  Ning Zhan; Bin Li; Xiangying Xu; Jianyu Xu; Songliu Hu
Journal:  Oncol Lett       Date:  2018-01-29       Impact factor: 2.967

3.  Pelvic radiation therapy: Between delight and disaster.

Authors:  Kirsten Al Morris; Najib Y Haboubi
Journal:  World J Gastrointest Surg       Date:  2015-11-27

4.  Effects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients.

Authors:  Alexander Gaber; Christina Stene; Kristina Hotakainen; Björn Nodin; Ingrid Palmquist; Anders Bjartell; Ulf-Håkan Stenman; Bengt Jeppsson; Louis B Johnson; Karin Jirström
Journal:  Radiat Oncol       Date:  2011-08-24       Impact factor: 3.481

Review 5.  Non-small cell lung cancer and CHART (continuous hyperfractionated accelerated radiotherapy)--where do we stand?

Authors:  R L Eakin; M I Saunders
Journal:  Ulster Med J       Date:  2000-11

6.  Expression levels of the DNA repair enzyme HAP1 do not correlate with the radiosensitivities of human or HAP1-transfected rat cell lines.

Authors:  C J Herring; B Deans; R H Elder; J A Rafferty; J MacKinnon; G Barzilay; I D Hickson; J H Hendry; G P Margison
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

7.  Antioxidant Supplementation: A Linchpin in Radiation-Induced Enteritis.

Authors:  Mumtaz Anwar; Shabeer Ahmad; Reyhan Akhtar; Akhtar Mahmood; Safrun Mahmood
Journal:  Technol Cancer Res Treat       Date:  2017-05-22

8.  Immunohistochemical expression of melan-A and tyrosinase in uveal melanoma.

Authors:  Bruno F Fernandes; Alexandre N Odashiro; Vinicius S Saraiva; Patrick Logan; Emilia Antecka; Miguel N Burnier
Journal:  J Carcinog       Date:  2007-04-20

9.  Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026.

Authors:  B P Nutley; N F Smith; A Hayes; L R Kelland; L Brunton; B T Golding; G C M Smith; N M B Martin; P Workman; F I Raynaud
Journal:  Br J Cancer       Date:  2005-10-31       Impact factor: 7.640

Review 10.  The need for laparoscopic ovarian transposition in young patients with cervical cancer undergoing radiotherapy.

Authors:  Hariyono Winarto; Eva Febia; Gatot Purwoto; Laila Nuranna
Journal:  Int J Reprod Med       Date:  2013-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.